BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10323642)

  • 1. Estrogen replacement therapy and cognitive decline in older community women.
    Matthews K; Cauley J; Yaffe K; Zmuda JM
    J Am Geriatr Soc; 1999 May; 47(5):518-23. PubMed ID: 10323642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen replacement therapy and cognitive functioning in the Atherosclerosis Risk in Communities (ARIC) Study.
    Szklo M; Cerhan J; Diez-Roux AV; Chambless L; Cooper L; Folsom AR; Fried LP; Knopman D; Nieto FJ
    Am J Epidemiol; 1996 Dec; 144(11):1048-57. PubMed ID: 8942436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum estrogen levels, cognitive performance, and risk of cognitive decline in older community women.
    Yaffe K; Grady D; Pressman A; Cummings S
    J Am Geriatr Soc; 1998 Jul; 46(7):816-21. PubMed ID: 9670866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone therapy, timing of initiation, and cognition in women aged older than 60 years: the REMEMBER pilot study.
    MacLennan AH; Henderson VW; Paine BJ; Mathias J; Ramsay EN; Ryan P; Stocks NP; Taylor AW
    Menopause; 2006; 13(1):28-36. PubMed ID: 16607096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced cognitive performance with estrogen use in nondemented community-dwelling older women.
    Steffens DC; Norton MC; Plassman BL; Tschanz JT; Wyse BW; Welsh-Bohmer KA; Anthony JC; Breitner JC
    J Am Geriatr Soc; 1999 Oct; 47(10):1171-5. PubMed ID: 10522948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group.
    Gregg EW; Yaffe K; Cauley JA; Rolka DB; Blackwell TL; Narayan KM; Cummings SR
    Arch Intern Med; 2000 Jan; 160(2):174-80. PubMed ID: 10647755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postmenopausal hormone therapy and risk of cognitive decline in community-dwelling aging women.
    Kang JH; Weuve J; Grodstein F
    Neurology; 2004 Jul; 63(1):101-7. PubMed ID: 15249618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen replacement therapy and MRI-demonstrated cerebral infarcts, white matter changes, and brain atrophy in older women: the Cardiovascular Health Study.
    Luoto R; Manolio T; Meilahn E; Bhadelia R; Furberg C; Cooper L; Kraut M
    J Am Geriatr Soc; 2000 May; 48(5):467-72. PubMed ID: 10811537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen replacement therapy and cognitive function in older women.
    Barrett-Connor E; Kritz-Silverstein D
    JAMA; 1993 May; 269(20):2637-41. PubMed ID: 8487446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postmenopausal hormone therapy and cognitive function in healthy older women.
    Grodstein F; Chen J; Pollen DA; Albert MS; Wilson RS; Folstein MF; Evans DA; Stampfer MJ
    J Am Geriatr Soc; 2000 Jul; 48(7):746-52. PubMed ID: 10894312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term Cognitive Trajectories and Mortality in Older Women.
    Yaffe K; Peltz CB; Ewing SK; McCulloch CE; Cummings SR; Cauley JA; Hillier TA; Ensrud KE
    J Gerontol A Biol Sci Med Sci; 2016 Aug; 71(8):1074-80. PubMed ID: 26843186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor 1 polymorphisms and risk of cognitive impairment in older women.
    Yaffe K; Lui LY; Grady D; Stone K; Morin P
    Biol Psychiatry; 2002 Apr; 51(8):677-82. PubMed ID: 11955468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical cognitive decline and subsequent sleep disturbance in older women.
    Yaffe K; Blackwell T; Barnes DE; Ancoli-Israel S; Stone KL;
    Neurology; 2007 Jul; 69(3):237-42. PubMed ID: 17636060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone replacement therapy to maintain cognitive function in women with dementia.
    Hogervorst E; Yaffe K; Richards M; Huppert F
    Cochrane Database Syst Rev; 2002; (3):CD003799. PubMed ID: 12137718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between bone mineral density and cognitive decline in older women.
    Yaffe K; Browner W; Cauley J; Launer L; Harris T
    J Am Geriatr Soc; 1999 Oct; 47(10):1176-82. PubMed ID: 10522949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects.
    Henderson VW; Paganini-Hill A; Emanuel CK; Dunn ME; Buckwalter JG
    Arch Neurol; 1994 Sep; 51(9):896-900. PubMed ID: 8080389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive function and endogenous sex hormones in older women.
    Barrett-Connor E; Goodman-Gruen D
    J Am Geriatr Soc; 1999 Nov; 47(11):1289-93. PubMed ID: 10573435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen replacement therapy and longitudinal decline in visual memory. A possible protective effect?
    Resnick SM; Metter EJ; Zonderman AB
    Neurology; 1997 Dec; 49(6):1491-7. PubMed ID: 9409335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone replacement therapy and reduced cognitive decline in older women: the Cache County Study.
    Carlson MC; Zandi PP; Plassman BL; Tschanz JT; Welsh-Bohmer KA; Steffens DC; Bastian LA; Mehta KM; Breitner JC;
    Neurology; 2001 Dec; 57(12):2210-6. PubMed ID: 11756599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mood symptoms and cognitive performance in women estrogen users and nonusers and men.
    Miller KJ; Conney JC; Rasgon NL; Fairbanks LA; Small GW
    J Am Geriatr Soc; 2002 Nov; 50(11):1826-30. PubMed ID: 12410901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.